Avoro Capital Advisors LLC

Avoro Capital Advisors LLC reported 30 holdings worth US$9.69B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Avoro Capital Advisors LLC reported 30 holdings worth US$9.69B as of Sep 30, 2026. Largest: United Therapeutics Corporation, Krystal Biotech, Inc. and argenx SE. Filed Nov 16, 2026 (Form 13F).

Holdings
30
Value as reported
US$9.69B

The filing in full

CompanySharesValue as reported% of portfolio
United Therapeutics Corporation2.76MUS$1.49B15.4%
Krystal Biotech, Inc.2.89MUS$961M9.9%
argenx SE1MUS$959M9.9%
Madrigal Pharmaceuticals, Inc.1.83MUS$924M9.5%
Kymera Therapeutics, Inc.7.47MUS$836M8.6%
Arrowhead Pharmaceuticals, Inc.11MUS$720M7.4%
Revolution Medicines, Inc.2.15MUS$440M4.5%
Cytokinetics, Incorporated4.9MUS$323M3.3%
Definium Therapeutics, Inc.7.05MUS$268M2.8%
Structure Therapeutics, Inc.6.56MUS$205M2.1%
Xenon Pharmaceuticals Inc.5.5MUS$205M2.1%
Vera Therapeutics, Inc.5.63MUS$182M1.9%
Celcuity Inc.1.5MUS$119M1.2%
Taysha Gene Therapies, Inc.23.9MUS$116M1.2%
Ocular Therapeutix, Inc.12.4MUS$95M0.98%
Hemab Therapeutics Holdings, Inc.1.89MUS$58.4M0.60%
Viridian Therapeutics, Inc.2.5MUS$51.5M0.53%
Septerna, Inc.1.3MUS$50.9M0.52%
Abivax SA488KUS$48.3M0.50%
Scribe Therapeutics Inc.2.6MUS$47.8M0.49%
Sensei Biotherapeutics, Inc.1.41MUS$41.9M0.43%
Avalo Therapeutics, Inc.2.38MUS$36.5M0.38%
Braveheart Bio, Inc.1.25MUS$25.4M0.26%
Whitehawk Therapeutics, Inc.2.85MUS$10.7M0.11%
Lexeo Therapeutics, Inc.525KUS$1.77M0.02%
Damora Therapeutics, Inc.0US$00.00%

Source

Download original · View original at SEC

Related